These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31128006)

  • 1. Aclidinium Bromide holds promising inhibitory effects in A549 lung cancer cells potentials by regulating PI3K / AKT signaling pathway.
    Lin G; He Y; Han D; Shi D; Liu T; Gao Y; Guan W; Cheng G
    J BUON; 2019; 24(2):560-565. PubMed ID: 31128006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
    Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aclidinium bromide inhibits the growth and metastasis of gastric cancer MKN‑28 cells via the PI3K signaling pathway.
    Wang Y; Cui P; Liu J; Wu H; Ma J
    Mol Med Rep; 2018 Aug; 18(2):2263-2268. PubMed ID: 29956761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aclidinium bromide inhibits human glioma cell proliferation, migration and invasion and promotes apoptosis via the PI3K/AKT signaling pathway.
    Huang SH; Zhang T; Zhao CG; Qin J; Qi P; Li FT; He XJ
    Neoplasma; 2018 Nov; 65(6):865-871. PubMed ID: 29940755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
    Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
    Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
    Yin Y; Sui C; Meng F; Ma P; Jiang Y
    Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lappaconitine sulfate induces apoptosis and G0/G1 phase cell cycle arrest by PI3K/AKT signaling pathway in human non-small cell lung cancer A549 cells.
    Qu D; Ma J; Song N; Hui L; Yang L; Guo Y; Sang C
    Acta Histochem; 2020 Jul; 122(5):151557. PubMed ID: 32622431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis.
    Zheng CJ; Yang LL; Liu J; Zhong L
    J Recept Signal Transduct Res; 2018 Apr; 38(2):133-140. PubMed ID: 29447541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway.
    Hua R; Pei Y; Gu H; Sun Y; He Y
    J BUON; 2020; 25(1):262-267. PubMed ID: 32277640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sapylin inhibits lung cancer cell proliferation and promotes apoptosis by attenuating PI3K/AKT signaling.
    Zhang L; Liu B
    J Cell Biochem; 2019 Sep; 120(9):14679-14687. PubMed ID: 31009136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Nov; 40(5):2944-2954. PubMed ID: 30226581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring davanone terpenoid exhibits anticancer potential against ovarian cancer cells by inducing programmed cell death, by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signaling pathway.
    Cai J; Zhong YY; Tian S
    J BUON; 2020; 25(5):2301-2307. PubMed ID: 33277849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.